ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

Summary

ClearOne entered a definitive merger agreement under which Cortigent, developer of precision neurostimulation brain implants for vision restoration (Orion system) and motor recovery after stroke, will become a wholly-owned subsidiary; the combined company will be renamed Cortigent Holdings. The transaction advances cortical stimulation technology with prior FDA Breakthrough Device designation.